tetracaine has been researched along with masoprocol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ishii, M; Kato, R; Nakadate, T; Yamamoto, S | 1 |
2 other study(ies) available for tetracaine and masoprocol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
Topics: Animals; Antioxidants; Arachidonic Acid; Arachidonic Acids; Carboxy-Lyases; Catechols; Dinoprostone; Female; Indomethacin; Lipoxygenase Inhibitors; Masoprocol; Mice; Ornithine Decarboxylase; Phorbols; Phospholipases; Phospholipases A; Phospholipases A2; Prostaglandins E; Quinacrine; Skin; Tetracaine; Tetradecanoylphorbol Acetate | 1982 |